FI943733A0 - Amadori reaction compounds and products, a process for their preparation and their use - Google Patents
Amadori reaction compounds and products, a process for their preparation and their useInfo
- Publication number
- FI943733A0 FI943733A0 FI943733A FI943733A FI943733A0 FI 943733 A0 FI943733 A0 FI 943733A0 FI 943733 A FI943733 A FI 943733A FI 943733 A FI943733 A FI 943733A FI 943733 A0 FI943733 A0 FI 943733A0
- Authority
- FI
- Finland
- Prior art keywords
- pct
- compounds
- group
- aminoacid
- deoxy
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 238000003691 Amadori rearrangement reaction Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 abstract 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 abstract 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 2
- 208000007976 Ketosis Diseases 0.000 abstract 2
- 235000001014 amino acid Nutrition 0.000 abstract 2
- 229940024606 amino acid Drugs 0.000 abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 abstract 2
- 108090000765 processed proteins & peptides Chemical class 0.000 abstract 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 abstract 1
- MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 abstract 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 abstract 1
- SHZGCJCMOBCMKK-QYESYBIKSA-N 6-deoxyglucose Chemical compound C[C@@H]1O[C@H](O)[C@@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-QYESYBIKSA-N 0.000 abstract 1
- 239000004475 Arginine Substances 0.000 abstract 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 abstract 1
- 108090000695 Cytokines Proteins 0.000 abstract 1
- 102000004127 Cytokines Human genes 0.000 abstract 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 abstract 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 abstract 1
- 229930091371 Fructose Natural products 0.000 abstract 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 abstract 1
- 239000005715 Fructose Substances 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 abstract 1
- 239000004471 Glycine Substances 0.000 abstract 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 abstract 1
- 102000014150 Interferons Human genes 0.000 abstract 1
- 108010050904 Interferons Proteins 0.000 abstract 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 abstract 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 abstract 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 abstract 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 abstract 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 abstract 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 abstract 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 abstract 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 abstract 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 abstract 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 abstract 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 abstract 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 abstract 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 abstract 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 abstract 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 abstract 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 abstract 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 abstract 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 abstract 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 1
- 239000004472 Lysine Substances 0.000 abstract 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 abstract 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 abstract 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 abstract 1
- 239000006035 Tryptophane Substances 0.000 abstract 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 abstract 1
- 235000004279 alanine Nutrition 0.000 abstract 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 abstract 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 abstract 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract 1
- 235000009697 arginine Nutrition 0.000 abstract 1
- 235000009582 asparagine Nutrition 0.000 abstract 1
- 229960001230 asparagine Drugs 0.000 abstract 1
- 235000003704 aspartic acid Nutrition 0.000 abstract 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 abstract 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 abstract 1
- 235000018417 cysteine Nutrition 0.000 abstract 1
- 229960002433 cysteine Drugs 0.000 abstract 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 abstract 1
- 229960003067 cystine Drugs 0.000 abstract 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 abstract 1
- 229930182830 galactose Natural products 0.000 abstract 1
- 229960002442 glucosamine Drugs 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 235000013922 glutamic acid Nutrition 0.000 abstract 1
- 239000004220 glutamic acid Substances 0.000 abstract 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 abstract 1
- 229960002743 glutamine Drugs 0.000 abstract 1
- 150000004676 glycans Chemical class 0.000 abstract 1
- 235000014304 histidine Nutrition 0.000 abstract 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 abstract 1
- 229960002591 hydroxyproline Drugs 0.000 abstract 1
- 229940079322 interferon Drugs 0.000 abstract 1
- 229960000310 isoleucine Drugs 0.000 abstract 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 abstract 1
- 210000000265 leukocyte Anatomy 0.000 abstract 1
- 229930182817 methionine Natural products 0.000 abstract 1
- 229960004452 methionine Drugs 0.000 abstract 1
- 150000002482 oligosaccharides Polymers 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 abstract 1
- 235000008729 phenylalanine Nutrition 0.000 abstract 1
- 229920001282 polysaccharide Polymers 0.000 abstract 1
- 239000005017 polysaccharide Substances 0.000 abstract 1
- 235000013930 proline Nutrition 0.000 abstract 1
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 abstract 1
- 235000021309 simple sugar Nutrition 0.000 abstract 1
- 235000000346 sugar Nutrition 0.000 abstract 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 abstract 1
- -1 treonine Chemical compound 0.000 abstract 1
- 229960004799 tryptophan Drugs 0.000 abstract 1
- 229960004441 tyrosine Drugs 0.000 abstract 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 abstract 1
- 229960004295 valine Drugs 0.000 abstract 1
- 239000004474 valine Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
- C07H7/02—Acyclic radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Polymers & Plastics (AREA)
- Materials Engineering (AREA)
- General Chemical & Material Sciences (AREA)
- Transplantation (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
PCT No. PCT/EP93/00327 Sec. 371 Date Oct. 24, 1994 Sec. 102(e) Date Oct. 24, 1994 PCT Filed Feb. 11, 1993 PCT Pub. No. WO93/16087 PCT Pub. Date Aug. 19, 1993Novel Amadori reaction compounds have the formula R1-NH-R2, wherein R1 comprises the D-form of a 1-amino-1-deoxy-2-ketose radical derived from a sugar radical selected from the group of glucose, xylose, galactose, rhamnose, fructose, mannose, 6-deoxyglucose, glucosamine and galactosamine, and R2 comprises the L-form of an aminoacid or peptide radical selected from the group of serine, glycine, proline, histidine, arginine, alanine, aspartic acid, glutamic acid, phenylalanine, treonine, cysteine, cystine, glutamine, asparagine, methionine, tyrosine, hydroxyproline, tryptophane, valine isoleucine, lysine and leucine. Compounds and combinations of compounds having the general formula R1'-NH-R2', wherein R1' comprises a 1-amino-1-deoxy-2-ketose radical derived from the group of simple sugars, oligo- and polysaccharides, and R2' comprises an aminoacid or a peptide radical, are used to produce pharmaceutical preparations which in contact with human leukocytes produce interferon and other cytokines.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL29346492A PL171023B1 (en) | 1992-02-13 | 1992-02-13 | Method of obtaining novel cytokine inductors |
| EP92103614 | 1992-03-03 | ||
| PCT/EP1993/000327 WO1993016087A2 (en) | 1992-02-13 | 1993-02-11 | Amadori reaction compounds and products, process for their manufacture, and their use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI943733A FI943733A (en) | 1994-08-12 |
| FI943733A0 true FI943733A0 (en) | 1994-08-12 |
Family
ID=26130822
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI943733A FI943733A0 (en) | 1992-02-13 | 1994-08-12 | Amadori reaction compounds and products, a process for their preparation and their use |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5723504A (en) |
| JP (1) | JPH07506344A (en) |
| AT (1) | ATE187734T1 (en) |
| AU (1) | AU672595B2 (en) |
| BG (1) | BG62172B1 (en) |
| BR (1) | BR9305878A (en) |
| CA (1) | CA2130106A1 (en) |
| CZ (1) | CZ285200B6 (en) |
| DE (2) | DE632813T1 (en) |
| ES (1) | ES2072244T1 (en) |
| FI (1) | FI943733A0 (en) |
| GR (1) | GR950300017T1 (en) |
| HU (1) | HUT70434A (en) |
| MX (1) | MX9300759A (en) |
| NO (1) | NO304026B1 (en) |
| RO (1) | RO115633B1 (en) |
| RU (1) | RU2141337C1 (en) |
| SG (1) | SG52390A1 (en) |
| SK (1) | SK86994A3 (en) |
| TW (1) | TW302368B (en) |
| WO (1) | WO1993016087A2 (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5629412A (en) * | 1994-07-11 | 1997-05-13 | Glinskii; Guennadi V. | Synthetic glycoamines that promote or inhibit cell adhesion |
| FR2746316B1 (en) * | 1996-03-19 | 1998-06-12 | Guerlain | NEW COSMETOLOGICAL OR DERMATOLOGICAL COMPOSITIONS |
| WO1997049389A1 (en) * | 1996-06-27 | 1997-12-31 | The Picower Institute For Medical Research | 3-alkylamino-2-hydroxy-4-hydroxymethyl-2-cyclopenten-1-one advanced glycosylation endproducts and methods of use therefor |
| DE19705233A1 (en) * | 1997-02-12 | 1998-08-13 | Froelich Juergen C | Preparation of stable, orally administered arginine solutions |
| GB0319463D0 (en) * | 2003-08-20 | 2003-09-17 | Givaudan Sa | Compounds |
| TW200925268A (en) * | 2007-12-06 | 2009-06-16 | Mallinckrodt Baker Inc | Fluoride-containing photoresist stripper or residue removing cleaning compositions containing conjugate oligomeric or polymeric material of alpha-hydroxycarbonyl compound/amine or ammonia reaction |
| JP2012140360A (en) * | 2010-12-28 | 2012-07-26 | Kracie Home Products Ltd | Antioxidant, cosmetic, food and drink composition and pharmaceutical composition |
| JP5835894B2 (en) * | 2010-12-29 | 2015-12-24 | クラシエホームプロダクツ株式会社 | Tyrosinase activity inhibitor, melanin production inhibitor and whitening agent, and cosmetics, food and beverage compositions and pharmaceutical compositions containing them |
| JP2012140378A (en) * | 2010-12-29 | 2012-07-26 | Kracie Home Products Ltd | Tyrosinase activity inhibitor, melanin production inhibitor and beautifying and whitening agent, and cosmetic, food and drink composition and pharmaceutical composition each comprising these |
| JP2012140377A (en) * | 2010-12-29 | 2012-07-26 | Kracie Home Products Ltd | Tyrosinase activity inhibitor, melanin production inhibitor and beautifying and whitening agent, and cosmetic, food and drink composition and pharmaceutical composition each comprising these |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1514910A (en) * | 1974-07-02 | 1978-06-21 | Unilever Ltd | Amadori compounds and their use to flavour foods |
| US4629692A (en) * | 1982-12-06 | 1986-12-16 | Miles Laboratories, Inc. | Immunoassay for nonenzymatically glucosylated proteins and protein fragments an index of glycemia |
| DE3405841A1 (en) * | 1984-02-17 | 1985-08-22 | Bayer Ag, 5090 Leverkusen | N-ACYLATED 1-ALKYLAMINO-1-DESOXY-KETOSE DERIVATIVES, METHOD FOR THE PRODUCTION AND THEIR USE |
| DE3601472A1 (en) * | 1986-01-20 | 1987-07-23 | Fresenius Ag | Use of reaction products of reducing sugars and serotonin or serotonin precursors for the treatment of cerebral disorders |
| GB2218102B (en) * | 1988-04-08 | 1992-09-16 | Sandoz Ltd | Calcitonin peptide derivatives |
| DE69224024T2 (en) * | 1991-03-16 | 1998-08-27 | Torf Ets | TORF-DERIVATED BIOACTIVE PRODUCTS AND THEIR CONTAINING PHARMACEUTICAL AND COSMETIC COMPOSITIONS |
-
1993
- 1993-02-11 WO PCT/EP1993/000327 patent/WO1993016087A2/en active IP Right Grant
- 1993-02-11 DE DE0632813T patent/DE632813T1/en active Pending
- 1993-02-11 SG SG1996003877A patent/SG52390A1/en unknown
- 1993-02-11 SK SK869-94A patent/SK86994A3/en unknown
- 1993-02-11 RO RO94-01361A patent/RO115633B1/en unknown
- 1993-02-11 BR BR9305878A patent/BR9305878A/en not_active Application Discontinuation
- 1993-02-11 JP JP5513786A patent/JPH07506344A/en not_active Ceased
- 1993-02-11 US US08/284,635 patent/US5723504A/en not_active Expired - Fee Related
- 1993-02-11 CA CA002130106A patent/CA2130106A1/en not_active Abandoned
- 1993-02-11 AU AU34966/93A patent/AU672595B2/en not_active Ceased
- 1993-02-11 HU HU9402347A patent/HUT70434A/en unknown
- 1993-02-11 DE DE69327310T patent/DE69327310D1/en not_active Expired - Lifetime
- 1993-02-11 ES ES93903950T patent/ES2072244T1/en active Pending
- 1993-02-11 RU RU94040167A patent/RU2141337C1/en active
- 1993-02-11 AT AT93903950T patent/ATE187734T1/en not_active IP Right Cessation
- 1993-02-11 CZ CZ941945A patent/CZ285200B6/en not_active IP Right Cessation
- 1993-02-12 MX MX9300759A patent/MX9300759A/en unknown
- 1993-03-23 TW TW082102133A patent/TW302368B/zh active
-
1994
- 1994-08-05 BG BG98956A patent/BG62172B1/en unknown
- 1994-08-08 NO NO942930A patent/NO304026B1/en unknown
- 1994-08-12 FI FI943733A patent/FI943733A0/en unknown
-
1995
- 1995-04-30 GR GR950300017T patent/GR950300017T1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU3496693A (en) | 1993-09-03 |
| GR950300017T1 (en) | 1995-04-30 |
| CZ194594A3 (en) | 1994-12-15 |
| DE632813T1 (en) | 1996-02-15 |
| BG98956A (en) | 1995-07-28 |
| NO304026B1 (en) | 1998-10-12 |
| RU94040167A (en) | 1996-07-10 |
| CA2130106A1 (en) | 1993-08-14 |
| ES2072244T1 (en) | 1995-07-16 |
| RU2141337C1 (en) | 1999-11-20 |
| BG62172B1 (en) | 1999-04-30 |
| MX9300759A (en) | 1993-11-01 |
| FI943733A (en) | 1994-08-12 |
| NO942930L (en) | 1994-08-08 |
| SK86994A3 (en) | 1995-02-08 |
| ATE187734T1 (en) | 2000-01-15 |
| HU9402347D0 (en) | 1994-10-28 |
| WO1993016087A3 (en) | 1993-09-16 |
| HUT70434A (en) | 1995-10-30 |
| WO1993016087A2 (en) | 1993-08-19 |
| CZ285200B6 (en) | 1999-06-16 |
| DE69327310D1 (en) | 2000-01-20 |
| JPH07506344A (en) | 1995-07-13 |
| NO942930D0 (en) | 1994-08-08 |
| US5723504A (en) | 1998-03-03 |
| SG52390A1 (en) | 1998-09-28 |
| RO115633B1 (en) | 2000-04-28 |
| AU672595B2 (en) | 1996-10-10 |
| TW302368B (en) | 1997-04-11 |
| BR9305878A (en) | 1997-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU95112539A (en) | New polypeptide and pharmaceutical composition for hiv-infection control | |
| FI953658A0 (en) | Stable bactericidal / permeability enhancing protein products and pharmaceutical compositions containing them | |
| FI943733A0 (en) | Amadori reaction compounds and products, a process for their preparation and their use | |
| TR199700685A2 (en) | The variants of insulin that are linked to zinc. | |
| KR890013061A (en) | Polypeptide derivatives | |
| DE3751398D1 (en) | Substrate peptides. | |
| DE3370026D1 (en) | Biologically active conjugates and their preparation and use | |
| ATE217530T1 (en) | PROTEOGLYCAN EFFECTIVE TO INCREASE ANTI-TUMOR IMMUNITY (G009) | |
| GB1461106A (en) | Gastric acid-inhibiting polypeptide | |
| KR920012114A (en) | Selected peptides of group-specific antigens (gaa) of human immunodeficiency virus (HIV), their preparation and use | |
| EP0740935A4 (en) | Analgesic activity enhancer | |
| EP0361956A3 (en) | Increased expression of small molecular weight recombinant proteins | |
| SE9402253D0 (en) | Process | |
| EP0632813B1 (en) | Amadori reaction compounds and products, process for their manufacture, and their use | |
| RU95105590A (en) | Hepatotropic conjugates of antiviral medicinal agents, their carriers, pharmaceutical compositions containing thereof, method of conjugates preparing | |
| KR920011512A (en) | Protein polysaccharide with antitumor immune enhancing effect (S 818) | |
| ES380245A1 (en) | Procedure for the obtaining of polypeptide derivatives. (Machine-translation by Google Translate, not legally binding) |